425 related articles for article (PubMed ID: 34031575)
1. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.
Oellerich M; Sherwood K; Keown P; Schütz E; Beck J; Stegbauer J; Rump LC; Walson PD
Nat Rev Nephrol; 2021 Sep; 17(9):591-603. PubMed ID: 34031575
[TBL] [Abstract][Full Text] [Related]
2. Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation.
Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
Ther Drug Monit; 2023 Feb; 45(1):20-25. PubMed ID: 36127770
[TBL] [Abstract][Full Text] [Related]
3. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
[TBL] [Abstract][Full Text] [Related]
5. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
[TBL] [Abstract][Full Text] [Related]
8. Donor-derived cell-free DNA as a diagnostic tool in transplantation.
Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
Front Genet; 2022; 13():1031894. PubMed ID: 36339004
[TBL] [Abstract][Full Text] [Related]
9. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
Transpl Int; 2023; 36():11899. PubMed ID: 38020751
[TBL] [Abstract][Full Text] [Related]
10. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
[TBL] [Abstract][Full Text] [Related]
11. Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation.
Baumann AK; Beck J; Kirchner T; Hartleben B; Schütz E; Oellerich M; Wedemeyer H; Jaeckel E; Taubert R
Liver Transpl; 2022 Dec; 28(12):1911-1919. PubMed ID: 35429207
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
[TBL] [Abstract][Full Text] [Related]
13. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
[TBL] [Abstract][Full Text] [Related]
14. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
[TBL] [Abstract][Full Text] [Related]
15. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
[TBL] [Abstract][Full Text] [Related]
16. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
[TBL] [Abstract][Full Text] [Related]
17. Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies.
Chang JH; Alvarado Verduzco H; Toma K; Sritharan S; Mohan S; Husain SA
Clin Transplant; 2022 Apr; 36(4):e14561. PubMed ID: 34913202
[TBL] [Abstract][Full Text] [Related]
18. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
[TBL] [Abstract][Full Text] [Related]
19. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
Stites E; Kumar D; Olaitan O; John Swanson S; Leca N; Weir M; Bromberg J; Melancon J; Agha I; Fattah H; Alhamad T; Qazi Y; Wiseman A; Gupta G
Am J Transplant; 2020 Sep; 20(9):2491-2498. PubMed ID: 32056331
[TBL] [Abstract][Full Text] [Related]
20. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
